Market Size of Contraceptive Pills Industry
Study Period | 2021 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 9.00 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Contraceptive Pills Market Analysis
The contraceptive pills market is poised to register a CAGR of 9% during the forecast period.
The COVID-19 pandemic had a substantial impact on the contraceptive pills market. Several guidelines are being introduced about contraceptive pills that have benefitted the market during the COVID-19 pandemic. For instance, according to the guidelines by MoHFW published in October 2021 by the government of India, oral contraceptive pills should be freely available in all public health facilities (including the COVID care facilities). According to the same source, extra packets (at least two months' supply) of oral contraceptive pills can be handed over to repeat clients to avoid multiple contacts. Thus, the demand for contraceptive pills remained significant during the pandemic.
However, with the introduction of vaccines, government authorities and healthcare organizations have recommended reducing the consumption of contraceptive pills before administering vaccines. For instance, according to an April 2021 update by the Taiwan Centers for Disease Control, the Advisory Committee on Immunization Practices (ACIP), the ACIP made a resolution to add related reminding messages on the notice of "precautions to take before COVID-19 vaccination with AstraZeneca vaccine." Taking contraceptive pills and undergoing hormone therapy are risk factors for blood clotting, thus, people receiving these treatments are advised to pause the process at least 28 days before and after inoculation at this stage. Hence, the COVID-19 pandemic had a significant impact on the market initially. However, as the pandemic subsided, the market is expected to have a stable growth during the forecast period.
Furthermore, the increasing rate of unintended pregnancies is a major factor driving the demand for contraceptive pills, thereby contributing to the market growth. For instance, according to a March 2021 update by the United Nations Populations Fund, the number of unintended pregnancies was 1.4 million across 115 low- and middle-income countries. Thus, such statistics indicate the increasing demand for contraceptive pills across the globe, thereby contributing to the market growth.
Additonally, various initiatives taken by governments worldwide is also expected to boost the market growth. For instance, according to the Council of Ministers of Spain in May 2022, the Spainish government reformed the law regarding sexual and reproductive health and the voluntary interruption of pregnancy. New measures on sexuality education and contraception, menstrual health, pregnancy, childbirth, abortion, and reproductive violence was taken. It was also mentioned that the morning-after contraceptive pill will be made available free of charge in health centres and future public centres specialising in sexual and reproductive rights, and must be available in all pharmacies.
Moreover, several developments by key market players are expected to further boost the market growth. For instance, in April 2021, Mayne Pharma reported that the US FDA had approved NEXTSTELLIS (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) for the prevention of pregnancy. NEXTSTELLIS is the first and only contraceptive pill containing E4, a naturally occurring estrogen, now produced from a plant source, with a unique mechanism of action that offers potential advantages over other estrogens.
Therefore, owing to the abovementioned factors, the market studied is anticipated to witness growth over the forecast period. However, side effects associated with the use of contraceptive drugs and increased usage of alternative birth control methods are the factors expected to hinder market growth over the forecast period.
Contraceptive Pills Industry Segmentation
According to the scope of the report, a contraceptive pill is a kind of medicine with hormones, which generally comes in a pack and has proven to be a useful family planning tool, offering reliable access to birth-rate management.
The contraceptive pills market is expected to grow at a CAGR of 9% during the forecast period. The market is segmented by Hormone Type (Progestin Pills, Combination Pills (Monophasic, Triphasic, Other Combination Pills)), Category (Generic, Branded), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the market sizes and forecasts in terms of value in USD million for the above segments.
By Hormone Type | |||||
Progestin Pills | |||||
|
By Category | |
Generic | |
Branded |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Contraceptive Pills Market Size Summary
The contraceptive pills market is experiencing a robust growth trajectory, driven by various factors including the increasing rate of unintended pregnancies and supportive government initiatives worldwide. The market is expected to expand significantly over the forecast period, with the generic segment anticipated to witness substantial growth due to its affordability and widespread availability. The COVID-19 pandemic initially impacted the market, but guidelines allowing easier access to contraceptive pills helped maintain demand. As the pandemic subsided, the market began to stabilize, with ongoing developments in contraceptive technologies and policies further propelling growth. Key players in the industry are actively expanding their product portfolios through strategic initiatives, which are expected to enhance market dynamics.
In North America, particularly the United States, the contraceptive pills market holds a significant share due to advanced healthcare infrastructure and high awareness levels. The market is moderately consolidated, with major companies like Bayer AG, Amneal Pharmaceuticals LLC, Pfizer Inc., Mayne Pharma, and Teva Pharmaceuticals leading the charge. These companies are focusing on expanding their offerings through acquisitions and collaborations, which is likely to intensify competition and create opportunities for both new and established players. Additionally, initiatives by organizations such as the Bill & Melinda Gates Foundation aim to improve contraceptive technologies and support family planning, further boosting the adoption of oral contraceptive pills.
Contraceptive Pills Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Rate of Unintended Pregnancies
-
1.2.2 Growing Awareness about Contraceptive Pills and Ease of Use and Low Cost
-
-
1.3 Market Restraints
-
1.3.1 Side Effects Associated with the Use of Contraceptive Drugs
-
1.3.2 Increased Usage of Alternative Birth Control Methods
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value- USD million)
-
2.1 By Hormone Type
-
2.1.1 Progestin Pills
-
2.1.2 Combination Pills
-
2.1.2.1 Monophasic
-
2.1.2.2 Triphasic
-
2.1.2.3 Other Combination Pills
-
-
-
2.2 By Category
-
2.2.1 Generic
-
2.2.2 Branded
-
-
2.3 By Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Contraceptive Pills Market Size FAQs
What is the current Contraceptive Pills Market size?
The Contraceptive Pills Market is projected to register a CAGR of 9% during the forecast period (2024-2029)
Who are the key players in Contraceptive Pills Market?
Teva Pharmaceuticals, Bayer AG, Pfizer Inc., Amneal Pharmaceuticals LLC and Mayne Pharma are the major companies operating in the Contraceptive Pills Market.